Poland· PL-100402280
Shingrix
A zoster, gereinigtes antigen product containing szczepionka przeciw półpaścowi (rekombinowana, z adiuwantem), registered in Poland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Zoster, gereinigtes antigen is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BK03 (zoster, gereinigtes antigen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Zoster, gereinigtes antigen · ATC J07BK03
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka przeciw półpaścowi (rekombinowana, z adiuwantem)
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Country
- Poland (PL)
- ATC code
- J07BK03
- ATC class
- Zoster, gereinigtes Antigen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
1 priced- gtin05901549673036
- gtin05901549673043
- gtin059099913648851 fiol. proszku + 1 fiol. 0,5 ml zawiesinyPLN 751.16
- gtin04150137158702
- gtin05909991364892
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BK03
Zoster, gereinigtes antigen, as other registers publish it.
- NorwayShingrixGlaxoSmithKline Biologicals SA
- DenmarkShingrixGlaxoSmithKline Biologicals
- DenmarkShingrixGlaxoSmithKline Biologicals
- BelgiumShingrixGlaxoSmithKline Biologicals
- IcelandShingrixGlaxoSmithKline Biologicals S.A.*
- FinlandShingrixGlaxoSmithKline Biologicals SA
- FinlandShingrixGlaxoSmithKline Biologicals SA
- IcelandShingrixGlaxoSmithKline Biologicals S.A.*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/efa99648-0682-43fa-83df-b36acc9c6bf5 GET /v1/drugs/efa99648-0682-43fa-83df-b36acc9c6bf5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i zawiesina do sporządzania zawiesiny do wstrzykiwań",
"source": "urpl",
"strength": "-",
"packaging": "05909991364885 ¦ Rp ¦ EU/1/18/1272/001 ¦ 127033\n1 fiol. 50 mcg proszku ¦ 1 fiol. 0,5 ml zawiesiny\n¦ UR/Z/4c/181/22 - 04150137158702 ¦ UR/Z/4c/174/23 - 04150137158702\n05909991364892 ¦ Rp ¦ EU/1/18/1272/002 ¦ 127034\n10 fiol. 50 mcg proszku ¦ 10 fiol. 0,5 ml zawiesiny\n05901549673036 ¦ Rp ¦ EU/1/18/1272/003 ¦ 167849\n1 amp.-strzyk. 0,5 ml\n05901549673043 ¦ Rp ¦ EU/1/18/1272/004 ¦ 167850\n10 amp.-strzyk. 0,5 ml",
"substance": null,
"common_name": "Szczepionka przeciw półpaścowi (rekombinowana, z adiuwantem)",
"pl_product_id": "100402280",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about zoster, gereinigtes antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.